Condition
Hypertrophic Cardiomyopathy Without Obstruction
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Early P 1 (1)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07420907Recruiting
Study of the Progression of Chronic Cardiovascular Conditions
NCT07595354Not ApplicableRecruitingPrimary
Exercise Prescription in Children With Hypertrophic Cardiomyopathy
NCT06433050Early Phase 1RecruitingPrimary
Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy
Showing all 3 trials